Atomfair

Awaiting product image

Atomfair Allylglycine C5H9NO2

Description Allylglycine (CAS: 54594-06-8), also known as 2-Amino-4-pentenoic acid, is a non-proteinogenic amino acid with the molecular formula C5H9NO2. This compound is widely utilized in biochemical and neuroscientific research due to its role as an inhibitor of glutamate decarboxylase (GAD), an enzyme critical for GABA synthesis. Allylglycine is available in high-purity grades, ensuring optimal performance for in vitro and in vivo applications. Its structural similarity to natural amino acids makes it a valuable tool for studying neurotransmitter regulation, metabolic pathways, and enzyme mechanisms. Suitable for laboratory use only, this product is rigorously tested for quality and consistency.

Category:
Brands:

Description

Description

Allylglycine (CAS: 54594-06-8), also known as 2-Amino-4-pentenoic acid, is a non-proteinogenic amino acid with the molecular formula C5H9NO2. This compound is widely utilized in biochemical and neuroscientific research due to its role as an inhibitor of glutamate decarboxylase (GAD), an enzyme critical for GABA synthesis. Allylglycine is available in high-purity grades, ensuring optimal performance for in vitro and in vivo applications. Its structural similarity to natural amino acids makes it a valuable tool for studying neurotransmitter regulation, metabolic pathways, and enzyme mechanisms. Suitable for laboratory use only, this product is rigorously tested for quality and consistency.

  • CAS No: 54594-06-8
  • Molecular Formula: C5H9NO2
  • Molecular Weight: 115.13
  • Exact Mass: 115.063328530
  • Monoisotopic Mass: 115.063328530
  • IUPAC Name: 2-aminopent-4-enoic acid
  • SMILES: C=CCC(C(=O)O)N
  • Synonyms: 7685-44-1, 2-Amino-4-pentenoic acid, ALLYLGLYCINE, 1069-48-3, dl-c-Allylglycine

Application

Allylglycine is primarily used in neuroscience research to inhibit GABA synthesis, enabling studies on excitotoxicity and seizure mechanisms. It serves as a model compound for investigating amino acid metabolism and enzyme inhibition. Researchers also employ Allylglycine to explore the role of GABAergic signaling in neurological disorders such as epilepsy and Parkinson’s disease.

If you are interested or have any questions, please contact us at support@atomfair.com